David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Medical Ethics 31 (9):497-498 (2005)
The continuing debate about the use of human embryonic stem cell researchThere is a growing consensus among scientists worldwide that embryonic stem cell research will lead to the development of therapies for common diseases or conditions that affect millions of people, including neurological disease or injury, diabetes, and myocardial infarction. HES cells are also valuable tools in understanding early human developmental processes, cell division and differentiation mechanisms, drug discovery and toxicity testing, and for developing models of human diseases. At the same time many individuals profess to be outraged by the prospect of using human embryos for research and therapeutic purposes and some countries or states have declared such research to be unethical and have banned it. Many people also think it would be immoral to benefit from what they consider to be evil.Obviously all those who think HES cell research is immoral will wish to ensure not only that no HES cell therapies are developed but that they will not openly or inadvertently benefit from such therapies when they can avoid it. I have accordingly designed the following Advance Directive and here offer it as a service to all those offended by therapeutic and research use of human embryos.The design of this advance directive to protect embryos highlights an important point that is often overlooked, namely that those who object to HES cell research as unethical and block such research are committed in consistency to the rejection of any benefits or therapies, which may flow from such research. It is questionable whether these people will fully accept this consequence of opposition to HES cell research, and whether this rejection of HES cell research will be practically possible. (Once …
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Jim Stone (1994). Advance Directives, Autonomy and Unintended Death. Bioethics 8 (3):223–246.
Leslie Pickering Francis (1993). Advance Directives for Voluntary Euthanasia: A Volatile Combination? Journal of Medicine and Philosophy 18 (3):297-322.
David J. Doukas, Toni Antonucci & Daniel W. Gorenflo (1992). A Multigenerational Study on the Correlation of Values and Advance Directives. Ethics and Behavior 2 (1):51 – 59.
E. Furberg (2012). Advance Directives and Personal Identity: What Is the Problem? Journal of Medicine and Philosophy 37 (1):60-73.
Miguel A. Sanchez-Conzalez (1997). Advance Directives Outside the USA: Are They the Best Solution Everywhere? Theoretical Medicine and Bioethics 18 (3):283-301.
J. Vollmann (2001). Advance Directives in Patients with Alzheimer's Disease; Ethical and Clinical Considerations. Medicine, Health Care and Philosophy 4 (2):161-167.
Chris Hackler, Ray Moseley & Dorothy E. Vawter (eds.) (1989). Advance Directives in Medicine. Praeger.
Christopher Buford (2008). Advancing an Advance Directive Debate. Bioethics 22 (8):423-430.
Christopher Tollefsen (1998). Response to “Reassessing the Reliability of Advance Directives” by Thomas May (CQ Vol. 6, No. 5) Advance Directives and Voluntary Slavery. [REVIEW] Cambridge Quarterly of Healthcare Ethics 7 (4):405-413.
Stefania Negri (ed.) (2012). Self-Determination, Dignity and End-of-Life Care: Regulating Advance Directives in International and Comparative Perspective. M. Nijhoff Pub..
Violeta Be Irević (2010). End-of-Life Care in the 21st Century: Advance Directives in Universal Rights Discourse. Bioethics 24 (3):105-112.
David J. Doukas, Using the Family Covenant in Planning End-of-Life Care: Obligations and Promises of Patients, Families, and Physicians.
Tolga Guven & Gurkan Sert (2010). Advance Directives in Turkey's Cultural Context: Examining the Potential Benefits for the Implementation of Patient Rights. Bioethics 24 (3):127-133.
Hiroaki Miyata, Hiromi Shiraishi & Ichiro Kai (2006). Survey of the General Public's Attitudes Toward Advance Directives in Japan: How to Respect Patients' Preferences. [REVIEW] BMC Medical Ethics 7 (1):1-9.
Benjamin H. Levi & Michael J. Green (2010). Too Soon to Give Up: Re-Examining the Value of Advance Directives. American Journal of Bioethics 10 (4):3 – 22.
Sorry, there are not enough data points to plot this chart.
Added to index2010-08-24
Recent downloads (6 months)0
How can I increase my downloads?